Faranak Ansari
-
- Antibiotic Use and Resistance 6
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 1
- Clinical Biochemistry top 10%
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 1
-
- Patient Satisfaction in Healthcare 4
-
- Healthcare Systems and Technology 2
-
- Urinary Tract Infections Management 1
-
- Healthcare Policy and Management 1
-
- Infection Control in Healthcare 1
- Co-authors
- Herman GoossensPeter DaveyMats ErntellArno MüllerMatus FerechPeter ZarbVanessa VankerckhovenAnis Abobaker
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- European Journal of Clinical Pharmacology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- IranBelgiumUnited Kingdom
In The Last Decade
Faranak Ansari
7 papers receiving 438 citations
Peers
Comparison fields: 5 of 85
- Applied Microbiology and Biotechnology 325
- Molecular Medicine 60
- Critical Care and Intensive Care Medicine 61
- Clinical Biochemistry 68
- Geriatrics and Gerontology 39
Countries citing papers authored by Faranak Ansari
This map shows the geographic impact of Faranak Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faranak Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faranak Ansari more than expected).
Fields of papers citing papers by Faranak Ansari
This network shows the impact of papers produced by Faranak Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faranak Ansari. The network helps show where Faranak Ansari may publish in the future.
Co-authorship network
The 8 scholars most cited alongside Faranak Ansari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2011 | 16 | |
| 3 | 2009 | 182 | |
| 4 | 2008 | 40 | |
| 5 | 2003 | 177 | |
| 6 | 2001 | 21 | |
| 7 | 2001 | 14 | |
| 8 | 2000 | 1 |
About Faranak Ansari
Faranak Ansari is a scholar working on Applied Microbiology and Biotechnology, Toxicology and Geriatrics and Gerontology, having authored 8 papers that have together received 451 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Patient Satisfaction in Healthcare (4 papers), Healthcare Systems and Technology (2 papers), Urinary Tract Infections Management (1 paper), Healthcare Policy and Management (1 paper), Antibiotic Resistance in Bacteria (1 paper), Infection Control in Healthcare (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (325 citations), Molecular Medicine (60 citations) and Critical Care and Intensive Care Medicine (61 citations). Faranak Ansari has collaborated with scholars based in Iran, Belgium and United Kingdom. Frequent co-authors include Herman Goossens, Peter Davey, Mats Erntell, Arno Müller, Matus Ferech, Peter Zarb, Vanessa Vankerckhoven and Anis Abobaker. Their work appears in journals such as European Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Current Clinical Pharmacology and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.